The Clinical and Cost-Effectiveness of 4 Enzyme-Linked Immunosorbent Assay Kits for Monitoring Infliximab in Crohn Disease Patients: Protocol for a Validation Study

BACKGROUND: Currently, treatment decisions for people with Crohn disease are based on clinical judgment and trial and error. Consequently, people may continue to receive high drug dosages and experience unnecessary toxicity when it is possible to reduce or discontinue without a detrimental effect on...

Descripción completa

Detalles Bibliográficos
Autores principales: Langford, Thomas, Arkir, Zehra, Chalkidou, Anastasia, Goddard, Kate, Kaftantzi, Lamprini, Samaan, Mark, Irving, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications 2018
Materias:
Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6231806/
https://www.ncbi.nlm.nih.gov/pubmed/30341052
http://dx.doi.org/10.2196/11218

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6231806/
https://www.ncbi.nlm.nih.gov/pubmed/30341052
http://dx.doi.org/10.2196/11218

Ejemplares similares